| 000 | 01395 a2200397 4500 | ||
|---|---|---|---|
| 005 | 20250512201643.0 | ||
| 264 | 0 | _c19830225 | |
| 008 | 198302s 0 0 eng d | ||
| 022 | _a0166-3542 | ||
| 024 | 7 |
_a10.1016/0166-3542(82)90051-1 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHatcher, V A | |
| 245 | 0 | 0 |
_aArabinosyladenine monophosphate in genital herpes: a double-blind, placebo-controlled study. _h[electronic resource] |
| 260 |
_bAntiviral research _cOct 1982 |
||
| 300 |
_a283-90 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdministration, Topical |
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAntiviral Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aArabinonucleotides _xtherapeutic use |
| 650 | 0 | 4 | _aClinical Trials as Topic |
| 650 | 0 | 4 | _aDouble-Blind Method |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHerpes Genitalis _xdrug therapy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aRandom Allocation |
| 650 | 0 | 4 | _aRecurrence |
| 650 | 0 | 4 |
_aVidarabine Phosphate _xadministration & dosage |
| 700 | 1 | _aFriedman-Kien, A E | |
| 700 | 1 | _aMarcus, E L | |
| 700 | 1 | _aKlein, R J | |
| 773 | 0 |
_tAntiviral research _gvol. 2 _gno. 5 _gp. 283-90 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/0166-3542(82)90051-1 _zAvailable from publisher's website |
| 999 |
_c6185135 _d6185135 |
||